ORBIMED ADVISORS LLC Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$7.8B
Holdings
158
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (158 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —SYNLOGIC INC | 6,029,995 | $14.6B | 187.61% | |
| 102 | ACRSACLARIS THERAPEUTICS INC | 985,900 | $14.3B | 184.29% | |
| 103 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 2,956,124 | $14.0B | 180.52% | |
| 104 | LUNGPULMONX CORP | 435,000 | $13.9B | 179.34% | |
| 105 | CTMXCYTOMX THERAPEUTICS INC | 3,214,509 | $13.9B | 178.94% | |
| 106 | BNRBURNING ROCK BIOTECH LTD | 1,452,402 | $13.8B | 177.94% | |
| 107 | —FUSION PHARMACEUTICALS INC | 3,224,770 | $13.4B | 172.87% | |
| 108 | AMGNAMGEN INC | 57,100 | $12.8B | 165.15% | |
| 109 | CYBNEURCYBIN INC | 10,524,300 | $12.5B | 160.46% | |
| 110 | CGEMCULLINAN ONCOLOGY INC | 805,041 | $12.4B | 159.70% | |
| 111 | GLTOUSDGALECTO INC | 4,090,937 | $12.4B | 159.36% | |
| 112 | QUREUNIQURE NV | 585,574 | $12.1B | 156.14% | |
| 113 | BLUBELLUS HEALTH INC NEW | 1,454,800 | $11.7B | 150.39% | |
| 114 | —SONENDO INC | 1,968,180 | $11.3B | 145.75% | |
| 115 | —9 METERS BIOPHARMA INC | 10,275,887 | $10.1B | 129.29% | |
| 116 | —MAGENTA THERAPEUTICS INC | 2,250,953 | $10.0B | 128.20% | |
| 117 | —PROMETHEUS BIOSCIENCES INC | 250,000 | $9.9B | 127.08% | |
| 118 | —IMARA INC | 4,386,568 | $9.9B | 126.89% | |
| 119 | VORVOR BIOPHARMA INC | 833,333 | $9.7B | 124.48% | |
| 120 | AFIBACUTUS MED INC | 2,648,386 | $9.0B | 116.10% | |
| 121 | CVRXCVRX INC | 723,055 | $8.8B | 113.69% | |
| 122 | RAPTEURRAPT THERAPEUTICS INC | 217,000 | $8.0B | 102.46% | |
| 123 | 698ACHILLES THERAPEUTICS PLC | 1,584,845 | $7.9B | 102.08% | |
| 124 | GOSSGOSSAMER BIO INC | 683,000 | $7.7B | 99.31% | |
| 125 | —GRAYBUG VISION INC | 4,163,347 | $7.6B | 97.95% | |
| 126 | —ONCOCYTE CORP | 3,493,800 | $7.6B | 97.47% | |
| 127 | NAUTNAUTILUS BIOTECHNOLOGY INC | 1,452,774 | $7.5B | 96.74% | |
| 128 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 6,000,000 | $7.2B | 92.20% | |
| 129 | AVTEAEROVATE THERAPEUTICS INC | 535,714 | $6.3B | 81.20% | |
| 130 | NTLAINTELLIA THERAPEUTICS INC | 53,200 | $6.3B | 80.86% | |
| 131 | —SYROS PHARMACEUTICALS INC | 1,837,500 | $6.0B | 77.01% | |
| 132 | TARAPROTARA THERAPEUTICS INC | 830,641 | $5.6B | 72.08% | |
| 133 | NRIXNURIX THERAPEUTICS INC | 184,468 | $5.3B | 68.65% | |
| 134 | SRPTSAREPTA THERAPEUTICS INC | 58,700 | $5.3B | 67.96% | |
| 135 | NBPI MAB | 111,120 | $5.3B | 67.70% | |
| 136 | —HEALTH SCIENCES ACQ CORP 2 | 500,000 | $5.0B | 64.79% | |
| 137 | IPSCCENTURY THERAPEUTICS INC | 307,047 | $4.9B | 62.61% | |
| 138 | PHGEBIOMX INC | 2,813,489 | $4.5B | 57.88% | |
| 139 | ALXOALX ONCOLOGY HLDGS INC | 207,600 | $4.5B | 57.35% | |
| 140 | IFRXINFLARX NV | 875,297 | $4.2B | 53.56% | |
| 141 | —TALARIS THERAPEUTICS INC | 247,240 | $3.8B | 48.60% | |
| 142 | —FIELD TRIP HEALTH LTD | 1,538,470 | $3.7B | 47.85% | |
| 143 | INZYINOZYME PHARMA INC | 526,600 | $3.6B | 46.17% | |
| 144 | SGHTSIGHT SCIENCES INC | 200,000 | $3.5B | 45.18% | |
| 145 | ASNSUSDX4 PHARMACEUTICALS INC | 1,373,849 | $3.1B | 40.45% | |
| 146 | WHWKAADI BIOSCIENCE INC | 127,600 | $3.1B | 39.62% | |
| 147 | EXAIEUREXSCIENTIA PLC | 125,000 | $2.5B | 31.75% | |
| 148 | SURFUSDSURFACE ONCOLOGY INC | 467,945 | $2.2B | 28.76% | |
| 149 | —ASLAN PHARMACEUTICALS LTD | 1,970,000 | $2.2B | 28.36% | |
| 150 | DRUGBRIGHT MINDS BIOSCIENCES INC | 660,600 | $2.1B | 27.40% | |
| 151 | ADAGADAGENE INC | 263,176 | $2.1B | 27.29% | |
| 152 | —APTINYX INC | 749,500 | $2.0B | 25.72% | |
| 153 | GYRECATALYST BIOSCIENCES INC | 1,729,402 | $1.6B | 20.33% | |
| 154 | PYXSPYXIS ONCOLOGY INC | 143,640 | $1.6B | 20.26% | |
| 155 | —LANDOS BIOPHARMA INC | 283,217 | $1.4B | 17.47% | |
| 156 | CABACABALETTA BIO INC | 302,509 | $1.1B | 14.75% | |
| 157 | —LONGBOARD PHARMACEUTICALS IN | 113,500 | $554.0M | 7.12% | |
| 158 | AUGXAUGMEDIX INC | 88,363 | $278.0M | 3.57% | |
| 159 | —OWLET INC | 220,704 | $86.0M | 1.11% |
PreviousPage 2 of 2